Indian e-commerce companies in particular have been using their Facebook pages extensively to reach out to as many consumers as possible, apart from paid advertisements.
While investment activity jumped three to four times this year over last year for e-commerce, it has shown marginal growth (five per cent) in the case of consumer and retail
Ratan Tata has invested his own money into 3 high-growth online retail firms, which are yet to make a profit.
The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes
We are looking at a 600-bed hospital from the existing 230 beds, which will help us create new specialities.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Ebay India MD Latif Nathani says that Indian ecommerce has a long way to go before catching up with the Chinese market.
The Whopper creater has most of its burgers priced at par with McDonald's.
.jpg)
The Paris-based global drug giant announced last week that it would have the vaccine available by the first half of next year.
Future, which recently tied up with Amazon in India to sell its fashion and food products exclusively on the American giant's marketplace platform, is looking at a gross merchandise value of about Rs 6,000 crore (Rs 60 billion) in the next three years from the venture.
.jpg)
In his clearest message yet on the controversy over the safety of ENDS, health minister Harsh Vardhan ruled out their acceptability in the light of research findings by experts which have held that they are no less unsafe than the 'real thing', said a government statement.
NPPA suggests expanding the list of essential medicines whose prices are controlled
Domestic and foreign companies pour in a slew of investments in Gujarat.
According to eBay, the percentage of transactions during the festival season declined marginally in Delhi, Mumbai, Bengaluru and Chennai.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
Sun maintained it would retain the best of both organisations to build a global pharma company.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
US country head, key departmental heads leave; more likely to follow.
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
This was only four days after many aggrieved buyers chose social networking sites to attack Flipkart's 'Big Billion Day' discount this Monday (October 6), followed by an apology from the company's co-founders, Sachin and Binny Bansal.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances